IMS Health (NYSE: RX) today announced that John R. Walsh has been named senior vice president, Payer and Government Solutions, a new position. Previously, Walsh was senior vice president, Strategy and Business Development for IMS. He continues to report to David R. Carlucci, IMS chairman and CEO, and will be based in Norwalk, CT.
In his new role, Walsh is responsible for the continued expansion of IMS’s payer and government solutions initiatives in markets worldwide. He also will take the lead in driving the company’s comparative effectiveness research activities – supporting biopharmaceutical companies, private payers and governments, as well as employers, healthcare providers and patient groups, as they evaluate and compare the clinical and cost effectiveness of different treatment approaches.
“Private and public payers present a significant market opportunity for IMS, as they increasingly look to us for information and analytics to measure improvements in healthcare delivery and outcomes,” said Carlucci. “Jack has extensive business development and industry experience, and will leverage the full range of capabilities we’ve built in this space over the past several years to reach clients in a broader set of health industry sectors.”
Walsh’s roles during his 12 years at IMS have included responsibility for the company’s strategy, and for identifying and assessing acquisitions, alliances and new business opportunities. He also has served as vice president and Treasurer, and vice president of Investor Relations for IMS. Walsh holds a B.B.A. degree from the University of Notre Dame and an M.B.A. from the University of Chicago.
New center established to bridge AI technology and healthcare applications